Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.

Purpose: Recombinant human erythropoietin (rHuEPO) is known to increase thrombotic risk in patients and might have similar effects in athletes abusing the drug. rHuEPO is prohibited by anti-doping legislation, but this risk has not been investigated thoroughly. This analysis was designed to evaluate...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Applied Physiology Vol. 120; no. 8; pp. 1893 - 1905
Autores principales:	Heuberger, Jules A. A. C., Posthuma, Jelle J., Ziagkos, Dimitrios, Rotmans, Joris I., Daniels, Johannes M. A., Gal, Pim, Stuurman, Frederik E., Spronk, Henri M. H., Ten Cate, Hugo, Burggraaf, Jacobus, Moerland, Matthijs, Cohen, Adam F.
Formato:	research tables/charts randomized controlled trial Journal Article
Publicado:	Springer Nature Aug2020
Acceso en línea:	Ver este registro en EBSCOhost